PMID- 38516222
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240323
IS  - 2772-6533 (Electronic)
IS  - 2772-6533 (Linking)
VI  - 4
DP  - 2024 Jun
TI  - Health and illness beliefs in adults with tuberculosis infection during the 
      COVID-19 pandemic in the UK.
PG  - 100162
LID - 10.1016/j.dialog.2023.100162 [doi]
LID - 100162
AB  - BACKGROUND: COVID-19 disrupted the TB prevention programme in the UK, especially 
      for TB infection (TBI) care. We explore whether experience of the COVID-19 
      pandemic impacted on patients' perceptions of TBI and its treatment. METHODS: 
      Semi-structured interviews were conducted as part of the Research to Improve 
      Detection and Treatment of TBI (RID-TB) programme, exploring perceptual and 
      practical barriers to TBI treatment. Nineteen people diagnosed with TBI were 
      interviewed between August 2020 and April 2021. Recordings were transcribed and 
      analysed using a constant comparative approach, allowing for a dynamic and 
      iterative exploration of themes. Themes are organised using the Perceptions and 
      Practicalities Approach. FINDINGS: Some participants perceived TBI as a risk 
      factor for increased susceptibility to COVID-19, while some thought that 
      treatment for TBI might protect against COVID-19 or mitigate its effects. 
      Adaptations to TB services (e.g., remote follow-up) and integrated practices 
      during the COVID-19 restrictions (e.g., medication being posted) addressed some 
      practical barriers to TBI treatment. However, we identified beliefs about TBI and 
      COVID-19 that are likely to act as barriers to engagement with TBI treatment, 
      including: interpreting service delays as an indication of TBI not being serious 
      enough for treatment and concerns about contracting COVID-19 in TB clinics. 
      INTERPRETATION: COVID-19 and TBI service delays influence people's perceptions 
      and practical barriers to TBI treatment adherence. Failure to address these 
      beliefs may lead to people's concerns about their treatment not being fully 
      addressed. Utilised service adaptations like remote consultations to address 
      practical barriers may be relevant beyond COVID-19. FUNDING: NIHR RID-TB Program 
      (RP-PG-0217-20009).
CI  - (c) 2023 Published by Elsevier Inc. CC BY-NC-ND 4.0.
FAU - Kilic, Aysenur
AU  - Kilic A
AD  - School of Pharmacy, University College London, London, UK.
FAU - Clarke, Amy L
AU  - Clarke AL
AD  - School of Pharmacy, University College London, London, UK.
FAU - Moon, Zoe
AU  - Moon Z
AD  - School of Pharmacy, University College London, London, UK.
FAU - Hamada, Yohhei
AU  - Hamada Y
AD  - Institute for Global Health, University College London, London, UK.
FAU - Chan, Amy Hai Yan
AU  - Chan AHY
AD  - School of Pharmacy, University of Auckland, Auckland, New Zealand.
FAU - Rahman, Ananna
AU  - Rahman A
AD  - Department of Respiratory Medicine, Barts Health NHS Trust, London, UK.
FAU - Layton, Charlotte
AU  - Layton C
AD  - MRC Clinical Trials Unit, University College London, UK.
FAU - Griffiths, Chris J
AU  - Griffiths CJ
AD  - Centre for Primary Care, Wolfson Institute of Population Health, Faculty of 
      Medicine and Dentistry, Queen Mary University of London, London, UK.
FAU - Zenner, Dominik
AU  - Zenner D
AD  - Centre for Primary Care, Wolfson Institute of Population Health, Faculty of 
      Medicine and Dentistry, Queen Mary University of London, London, UK.
FAU - Powell, Ellen
AU  - Powell E
AD  - MRC Clinical Trials Unit, University College London, UK.
FAU - Kunst, Heinke
AU  - Kunst H
AD  - Respiratory Medicine, Queen Mary University of London, London, UK.
FAU - Lipman, Marc
AU  - Lipman M
AD  - Royal Free London NHS Foundation Trust, London, UK.
AD  - UCL-TB and UCL Respiratory, University College London, London, UK.
FAU - Mandelbaum, Mike
AU  - Mandelbaum M
AD  - TB Alert, Brighton, UK.
FAU - Papineni, Padmasayee
AU  - Papineni P
AD  - London Northwest University Healthcare NHS Trust, London, UK.
FAU - Tattersall, Tessa
AU  - Tattersall T
AD  - MRC Clinical Trials Unit, University College London, UK.
FAU - Duong, Trinh
AU  - Duong T
AD  - MRC Clinical Trials Unit, University College London, UK.
FAU - Abubakar, Ibrahim
AU  - Abubakar I
AD  - Institute for Global Health, University College London, London, UK.
FAU - Rangaka, Molebogeng X
AU  - Rangaka MX
AD  - Institute for Global Health, University College London, London, UK.
AD  - Division of Epidemiology and Biostatistics & CIDRI-AFRICA, University of Cape 
      Town, Cape Town, South Africa.
FAU - Horne, Robert
AU  - Horne R
AD  - School of Pharmacy, University College London, London, UK.
LA  - eng
PT  - Journal Article
DEP - 20231129
PL  - United States
TA  - Dialogues Health
JT  - Dialogues in health
JID - 9918506184906676
PMC - PMC10953974
OTO - NOTNLM
OT  - Covid-19
OT  - LTBI
OT  - health beliefs
OT  - perceptions
OT  - tuberculosis
COIS- None.
EDAT- 2024/03/22 06:44
MHDA- 2024/03/22 06:45
PMCR- 2023/11/29
CRDT- 2024/03/22 04:07
PHST- 2023/08/08 00:00 [received]
PHST- 2023/11/23 00:00 [revised]
PHST- 2023/11/27 00:00 [accepted]
PHST- 2024/03/22 06:45 [medline]
PHST- 2024/03/22 06:44 [pubmed]
PHST- 2024/03/22 04:07 [entrez]
PHST- 2023/11/29 00:00 [pmc-release]
AID - S2772-6533(23)00066-7 [pii]
AID - 100162 [pii]
AID - 10.1016/j.dialog.2023.100162 [doi]
PST - epublish
SO  - Dialogues Health. 2023 Nov 29;4:100162. doi: 10.1016/j.dialog.2023.100162. 
      eCollection 2024 Jun.